NYK · 2025-26
Landry Shamet
- PTS/G
- 9.3
- REB/G
- 1.8
- AST/G
- 1.4
- TS%
- 59.8%
- RNP
- -196.4
- PRF
- 660.0
Season RNP is higher than about ~24% of qualified players (same season as the leaderboard: 549 players with 5+ GP; rank 418). Population & rules →
Running Net Points are not opponent-adjusted. Use home/away and opponent labels as schedule context, not as adjustments to the stat.
Latest game — possession RNP
Fri · Apr 10 · vs TORHome · W 112–95
Game log
2025-26 · 51 games · through Fri · Apr 10
| Date | Opp | Res | MIN | FG | 3P | FT | PTS | REB | AST | RNP | TS% | PRF |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-10 | vs TOR | W | 28.4 | 3/7 | 2/5 | 0/0 | 8 | 1 | 1 | -3.8 | 57.1% | 11.0 |
| 2026-04-09 | vs BOS | W | 18.9 | 1/4 | 1/3 | 0/0 | 3 | 1 | 1 | -5.1 | 37.5% | 6.0 |
| 2026-04-06 | @ ATL | W | 21.3 | 0/2 | 0/1 | 1/2 | 1 | 1 | 1 | -5.8 | 17.4% | 3.0 |
| 2026-04-03 | vs CHI | W | 12.7 | 3/7 | 2/4 | 0/0 | 8 | 1 | 1 | 0.5 | 57.1% | 10.0 |
| 2026-03-20 | @ BKN | W | 21.6 | 1/5 | 1/4 | 0/0 | 3 | 3 | 1 | -4.9 | 30.0% | 5.0 |
| 2026-03-18 | @ MEM | W | 30.6 | 5/9 | 3/5 | 0/1 | 13 | 3 | 1 | -3.8 | 68.9% | 15.0 |
| 2026-03-17 | vs IND | W | 15.7 | 1/5 | 0/3 | 0/0 | 2 | 1 | 1 | -11.8 | 20.0% | 5.0 |
| 2026-03-15 | vs GSW | W | 26.9 | 3/10 | 2/8 | 2/2 | 10 | 1 | 0 | -4.0 | 46.0% | 10.0 |
| 2026-03-13 | @ IND | W | 36.6 | 2/7 | 2/7 | 3/5 | 9 | 5 | 0 | -5.8 | 48.9% | 9.0 |
| 2026-03-11 | @ UTA | W | 30.5 | 3/5 | 1/2 | 0/0 | 7 | 3 | 4 | -2.0 | 70.0% | 18.0 |
| 2026-03-09 | @ LAC | L | 22.9 | 3/12 | 3/12 | 0/0 | 9 | 1 | 0 | -8.0 | 37.5% | 9.0 |
| 2026-03-08 | @ LAL | L | 27.4 | 4/8 | 2/6 | 0/0 | 10 | 1 | 2 | -7.0 | 62.5% | 15.0 |
| 2026-03-06 | @ DEN | W | 19.0 | 3/5 | 2/4 | 2/2 | 10 | 3 | 0 | 3.6 | 85.0% | 10.0 |
| 2026-03-04 | vs OKC | L | 31.0 | 5/9 | 0/3 | 4/5 | 14 | 3 | 2 | -3.5 | 62.5% | 19.0 |
| 2026-03-03 | @ TOR | W | 24.1 | 5/11 | 2/7 | 0/0 | 12 | 0 | 0 | -5.3 | 54.5% | 12.0 |
| 2026-03-01 | vs SAS | W | 25.0 | 3/8 | 1/5 | 0/0 | 7 | 1 | 3 | -0.8 | 43.8% | 16.0 |
| 2026-02-27 | @ MIL | W | 22.6 | 5/8 | 5/7 | 0/0 | 15 | 0 | 3 | -6.8 | 93.8% | 23.0 |
| 2026-02-24 | @ CLE | L | 20.2 | 1/5 | 0/3 | 0/0 | 2 | 2 | 1 | -10.5 | 20.0% | 5.0 |
| 2026-02-22 | @ CHI | W | 23.3 | 5/9 | 4/8 | 2/3 | 16 | 2 | 0 | -2.9 | 77.5% | 16.0 |
| 2026-02-21 | vs HOU | W | 26.0 | 5/7 | 2/4 | 2/3 | 14 | 0 | 2 | -0.7 | 84.1% | 19.0 |
| 2026-02-19 | vs DET | L | 28.2 | 4/10 | 3/8 | 4/6 | 15 | 2 | 2 | -5.2 | 59.3% | 19.0 |
| 2026-02-11 | @ PHI | W | 24.0 | 4/6 | 1/3 | 0/0 | 9 | 1 | 5 | -0.5 | 75.0% | 22.0 |
| 2026-02-10 | vs IND | L | 37.7 | 6/14 | 4/11 | 1/3 | 17 | 2 | 1 | -6.8 | 55.5% | 19.0 |
| 2026-02-08 | @ BOS | W | 27.8 | 1/5 | 1/4 | 0/0 | 3 | 4 | 3 | -5.4 | 30.0% | 9.0 |
| 2026-02-06 | @ DET | L | 21.2 | 2/7 | 1/5 | 0/0 | 5 | 2 | 3 | -6.6 | 35.7% | 11.0 |
| 2026-02-04 | vs DEN | W | 35.9 | 6/15 | 4/10 | 0/0 | 16 | 2 | 3 | -3.0 | 53.3% | 25.0 |
| 2026-02-03 | @ WAS | W | 21.0 | 5/8 | 4/6 | 0/0 | 14 | 0 | 1 | -8.3 | 87.5% | 17.0 |
| 2026-02-01 | vs LAL | W | 26.4 | 8/13 | 6/10 | 1/2 | 23 | 3 | 1 | 4.9 | 82.9% | 26.0 |
| 2026-01-30 | vs POR | W | 18.7 | 1/6 | 1/4 | 0/0 | 3 | 1 | 2 | -2.1 | 25.0% | 8.0 |
| 2026-01-28 | @ TOR | W | 21.0 | 3/10 | 3/9 | 0/0 | 9 | 4 | 1 | 2.1 | 45.0% | 12.0 |
| 2026-01-27 | vs SAC | W | 17.3 | 1/3 | 0/0 | 0/0 | 2 | 1 | 3 | -3.9 | 33.3% | 10.0 |
| 2026-01-24 | @ PHI | W | 24.5 | 4/9 | 3/7 | 1/2 | 12 | 4 | 2 | -3.2 | 60.7% | 17.0 |
| 2026-01-21 | vs BKN | W | 15.2 | 6/7 | 6/6 | 0/0 | 18 | 1 | 2 | 0.9 | 128.6% | 23.0 |
| 2026-01-19 | vs DAL | L | 23.2 | 2/5 | 1/4 | 1/3 | 6 | 1 | 1 | -11.3 | 47.5% | 9.0 |
| 2026-01-17 | vs PHX | L | 14.4 | 1/3 | 0/2 | 3/3 | 5 | 1 | 0 | -2.7 | 57.9% | 5.0 |
| 2026-01-15 | @ GSW | L | 16.4 | 2/7 | 2/7 | 0/0 | 6 | 0 | 0 | -3.8 | 42.9% | 6.0 |
| 2025-11-22 | @ ORL | L | 2.7 | 0/0 | 0/0 | 0/0 | 0 | 0 | 2 | 1.0 | — | 5.0 |
| 2025-11-19 | @ DAL | W | 23.1 | 3/6 | 2/3 | 1/3 | 9 | 3 | 1 | -1.7 | 61.5% | 11.0 |
| 2025-11-17 | @ MIA | L | 39.4 | 2/11 | 1/7 | 5/6 | 10 | 3 | 4 | -4.9 | 36.7% | 19.0 |
| 2025-11-14 | vs MIA | W | 37.3 | 12/19 | 6/12 | 6/6 | 36 | 2 | 3 | 2.3 | 83.2% | 45.0 |
| 2025-11-12 | vs ORL | L | 27.1 | 4/6 | 1/3 | 2/3 | 11 | 3 | 1 | -7.5 | 75.1% | 14.0 |
| 2025-11-11 | vs MEM | W | 20.9 | 3/5 | 2/4 | 2/2 | 10 | 1 | 0 | -0.1 | 85.0% | 10.0 |
| 2025-11-09 | vs BKN | W | 21.3 | 2/5 | 2/4 | 2/4 | 8 | 1 | 3 | 1.6 | 59.2% | 17.0 |
| 2025-11-05 | vs MIN | W | 11.6 | 1/1 | 1/1 | 0/0 | 3 | 1 | 0 | -5.1 | 150.0% | 3.0 |
| 2025-11-03 | vs WAS | W | 24.6 | 3/8 | 2/6 | 3/3 | 11 | 5 | 0 | -2.0 | 59.0% | 11.0 |
| 2025-11-02 | vs CHI | W | 18.3 | 3/6 | 3/3 | 0/0 | 9 | 1 | 1 | -5.1 | 75.0% | 11.0 |
| 2025-10-31 | @ CHI | L | 14.6 | 1/5 | 1/5 | 1/2 | 4 | 1 | 0 | -7.9 | 34.0% | 4.0 |
| 2025-10-28 | @ MIL | L | 29.8 | 5/11 | 4/9 | 2/2 | 16 | 3 | 1 | -3.0 | 67.3% | 18.0 |
| 2025-10-26 | @ MIA | L | 15.6 | 0/4 | 0/4 | 0/0 | 0 | 1 | 1 | -8.2 | 0.0% | 3.0 |
| 2025-10-24 | vs BOS | W | 13.9 | 1/2 | 1/2 | 0/0 | 3 | 3 | 0 | -9.4 | 75.0% | 3.0 |
| 2025-10-22 | vs CLE | W | 13.8 | 2/4 | 2/3 | 3/3 | 9 | 2 | 1 | -3.3 | 84.6% | 12.0 |